Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

GF vs HERZ: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

HERZ Wins Head-to-Head Institutional Verdict (2–0 across 6 Pillars · 7–1 Matrix Metrics)

HERZ Overall Winner 6-Pillar Tally: GF 0 – 2 HERZ (4 Tie) Matrix Metrics: GF 1 – 7 HERZ

As of Nov 20, 2026, Herzfeld Credit Income Fund, Inc. (HERZ) is the stronger overall head-to-head candidate over NEW GERMANY FUND Inc (GF) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 2–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). GF carries a Unified Composite Score of 25.9/100 (SELL) at $9.60 (N/M Forward P/E, N/A operating margin), whereas HERZ carries 48.7/100 (HOLD) at $12.96 (N/M Forward P/E, 0.0% operating margin).

  • Technical & Structure Timing Caution: GF is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.2); meanwhile HERZ is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About GF vs HERZ
GF NYSE
NEW GERMANY FUND Inc
Institutional Equity
$9.60
-1.64% 1D
Market Cap $190.7M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.88β · 20% Vol
Unified Composite Score
25.9 / 100 SELL
Tech 6.0 Fund 44.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -4.7%), weak momentum, RSI 27
RSI-14: 27.2 · SMA20: $10.20 · SMA50: $10.43
HERZ NASDAQ Head-to-Head Winner
Herzfeld Credit Income Fund, Inc. Common Stock
Institutional Equity
$12.96
-0.31% 1D
Market Cap $40.2M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.26β · 20% Vol
Unified Composite Score
48.7 / 100 HOLD
Tech 60.0 Fund 57.0 Flow 50.0 Mom 59.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -6.7%), weak momentum, RSI 24
RSI-14: 24.4 · SMA20: $13.41 · SMA50: $14.55

6-Pillar Scorecard Institutional Category Breakdown (GF 0 – 2 HERZ)

Columns: Metric · GF · HERZ
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale HERZ
Revenue Growth (YoY) N/A +0.0%
Earnings Growth (YoY) N/A +0.0%
TTM Revenue (USD) N/A N/A
Market Cap $190.7M $40.2M
3. Profitability & Quality HERZ
Gross Margin N/A N/A
Operating Margin N/A 0.0%
Net Profit Margin N/A 0.0%
Return on Equity (ROE) N/A 0.0%
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE 0.0% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: GF (1) vs HERZ (7)
Institutional Metric GF HERZ Criterion Row Edge
Market Capitalization
Scale
$190.7M $40.2M Larger Scale GF
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A +0.0% Higher Growth HERZ
Operating Margin (TTM)
Profitability
N/A 0.0% Higher Margin HERZ
Net Profit Margin
Profitability
N/A 0.0% Higher Margin HERZ
Return on Equity (ROE)
Capital Efficiency
N/A 0.0% Higher ROE HERZ
52-Week Range Position
Momentum
1% ($10–$12) 64% ($2–$19) Stronger Trend HERZ
Beta / 30D Volatility
Risk Regime
0.88β · 20% Vol 0.26β · 20% Vol Lower Realized Risk HERZ
Unified Institutional Score
Composite Signal
25.9 / 100 (SELL) 48.7 / 100 (HOLD) Higher Composite HERZ
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (0.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon GF +6.75 pp
GF: -6.43% · HERZ: -13.18%
3M Horizon GF +3.37 pp
GF: -15.12% · HERZ: -18.49%
6M Horizon GF +13.21 pp
GF: -18.51% · HERZ: -31.72%
1Y Horizon HERZ +421.89 pp
GF: -7.6% · HERZ: +414.29%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GF vs HERZ. Trailing 12-month operating profitability (GF N/A vs HERZ 0.0%) and valuation multiples (GF N/M vs HERZ N/M Forward P/E) are benchmarked directly in Pillar 4 below.

GF ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
HERZ ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E0.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
GF UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GF Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HERZ UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact HERZ Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
GF Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with $190.7M market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
HERZ Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with $40.2M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ GF vs HERZ Key Questions & Quantitative Answers

As of Nov 20, 2026, Herzfeld Credit Income Fund, Inc. (HERZ) is the stronger overall head-to-head candidate over NEW GERMANY FUND Inc (GF) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 2–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). GF carries a Unified Composite Score of 25.9/100 (SELL) at $9.60 (N/M Forward P/E, N/A operating margin), whereas HERZ carries 48.7/100 (HOLD) at $12.96 (N/M Forward P/E, 0.0% operating margin). Technical & Structure Timing Caution: GF is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.2); meanwhile HERZ is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

HERZ leads the Growth & Scale pillar: GF posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with HERZ at +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, GF generates N/A in USD-normalized revenue versus N/A for HERZ. In operating R&D and SG&A reinvestment, GF deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for HERZ.

GF and HERZ trade at balanced relative valuation multiples. GF trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas HERZ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GF (N/A ROE) versus HERZ (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, GF carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.88β · 20% Vol realized risk). By comparison, HERZ carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.26β · 20% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.